1. Home
  2. ENGN vs DOUG Comparison

ENGN vs DOUG Comparison

Compare ENGN & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENGN
  • DOUG
  • Stock Information
  • Founded
  • ENGN 1999
  • DOUG 1911
  • Country
  • ENGN Canada
  • DOUG United States
  • Employees
  • ENGN N/A
  • DOUG N/A
  • Industry
  • ENGN
  • DOUG Building operators
  • Sector
  • ENGN
  • DOUG Real Estate
  • Exchange
  • ENGN Nasdaq
  • DOUG Nasdaq
  • Market Cap
  • ENGN 191.1M
  • DOUG 161.5M
  • IPO Year
  • ENGN N/A
  • DOUG N/A
  • Fundamental
  • Price
  • ENGN $3.83
  • DOUG $2.13
  • Analyst Decision
  • ENGN Buy
  • DOUG
  • Analyst Count
  • ENGN 7
  • DOUG 0
  • Target Price
  • ENGN $23.29
  • DOUG N/A
  • AVG Volume (30 Days)
  • ENGN 94.6K
  • DOUG 620.0K
  • Earning Date
  • ENGN 09-09-2025
  • DOUG 07-31-2025
  • Dividend Yield
  • ENGN N/A
  • DOUG N/A
  • EPS Growth
  • ENGN N/A
  • DOUG N/A
  • EPS
  • ENGN N/A
  • DOUG N/A
  • Revenue
  • ENGN N/A
  • DOUG $1,034,406,000.00
  • Revenue This Year
  • ENGN N/A
  • DOUG $17.61
  • Revenue Next Year
  • ENGN N/A
  • DOUG N/A
  • P/E Ratio
  • ENGN N/A
  • DOUG N/A
  • Revenue Growth
  • ENGN N/A
  • DOUG 8.69
  • 52 Week Low
  • ENGN $2.65
  • DOUG $1.35
  • 52 Week High
  • ENGN $11.00
  • DOUG $3.20
  • Technical
  • Relative Strength Index (RSI)
  • ENGN 56.57
  • DOUG 35.87
  • Support Level
  • ENGN $3.45
  • DOUG $2.69
  • Resistance Level
  • ENGN $3.94
  • DOUG $3.03
  • Average True Range (ATR)
  • ENGN 0.27
  • DOUG 0.18
  • MACD
  • ENGN 0.00
  • DOUG -0.03
  • Stochastic Oscillator
  • ENGN 76.06
  • DOUG 9.36

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

About DOUG Douglas Elliman Inc.

Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.

Share on Social Networks: